Back to top
more

Aetna Inc. (AET)

(Delayed Data from NYSE)

$212.70 USD

212.70
NA

+0.70 (0.33%)

Updated Nov 28, 2018 04:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Versartis, Inc. (VSAR) in Focus: Stock Moves 11.5% Higher

by Zacks Equity Research

Versartis, Inc. (VSAR) was a big mover last session, as the company saw its shares rise over 11% on the day.

    Envision Healthcare Makes Organizational Changes, Here's Why

    by Zacks Equity Research

    Envision Healthcare (EVHC) rejigs top management and announces share buyback as it realigns business.

      Mednax Stock Down 35% Year to Date: Will It Fall Further?

      by Zacks Equity Research

      Mednax (MD) is possibly suffering from decline in business volumes along with cost inflation, which is expected to pressurize the margins in the coming quarters.

        Public Exchange Woes Hit Health Insurers: Stocks in Focus

        by Zacks Equity Research

        The U.S private health insurers have been incurring mounting losses from the health insurance marketplace. This has led many of them to pull back participation, worsening the scenario for underprivileged Americans.

          Arpita Dutt headshot

          Graham-Cassidy Obamacare Repeal Bill Picks Pace: Here's What You Need to Know

          by Arpita Dutt

          With the Graham-Cassidy Obamacare repeal bill picking pace, hospital stocks and insurance stocks like Aetna, Inc. (AET) will be in focus in the coming days.

            5 Reasons Why You Should Buy Aetna's (AET) Stock Right Now

            by Zacks Equity Research

            Aetna's (AET) consistent solid performance, strong balance sheet, cost reduction and product diversification are likely to yield positive results for the stock.

              4 HMO Stocks Standing Out in a Top-Ranked Industry

              by Zacks Equity Research

              HMO stocks looks poised for strong growth given their favorable fundamentals in a top-ranked industry.

                Centene Corporation (CNC) Catches Eye: Stock Jumps 8%

                by Zacks Equity Research

                Centene Corporation (CNC) saw its shares rise over 8% on the day after the company signed an agreement to buy all the assets of Fidelis Care for $3.75 billion in order to expand operation in New York.

                  Why the Earnings Streak Will Continue for Aetna Inc. (AET)

                  by Zacks Equity Research

                  Aetna Inc. (AET) can be a harbinger of out performance and a signal for a strong earnings profile on the back of its favorable Zacks rank and earnings ESP in the positive territory.

                    Centene's Fidelis Care Buyout to Expand Presence in New York

                    by Zacks Equity Research

                    Centene's (CNC) acquisition of Fidelis Care for $3.75 billion for expanding in New York, is expected to impact Centene's top line and bottom line positively.

                      3 Value Stocks in Health Insurance to Bet On

                      by Zacks Equity Research

                      The Health Insurance industry gains from growing government business, benefits of ACA, business diversification and profit-boosting medical plans despite regulatory hurdles

                        Cigna Shares (CI) Up 38% This Year: Is Further Upside Left?

                        by Zacks Equity Research

                        A mix of factors, ranging from industry to company-specific, are favoring the stock of Cigna (CI), driving solid returns.

                          Universal Health (UHS) Grows on Buyouts, Expenses a Drag

                          by Zacks Equity Research

                          Despite solid revenue growth backed by inorganic strategies, Universal Health's (UHS) rising level of debt and expenses continue to weigh on margins.

                            Acadia Healthcare (ACHC) Up 42% This Year: Is Upside Left?

                            by Zacks Equity Research

                            A mix of factors ranging from industry to company specific favor the stock of Acadia Healthcare (ACHC), helping it to drive solid returns.

                              Ensign Group's Inorganic Growth Impresses, Debt Level Hurts

                              by Zacks Equity Research

                              Ensign Group's (ENSG) top line rises on inorganic and organic growth. Its financial health also impresses. However high level of costs and debts bother.

                                Molina Healthcare's Top Line Grows on Membership, Debts Hurt

                                by Zacks Equity Research

                                Molina Healthcare's (MOH) top line benefits from inorganic growth and membership. However, rising level of debt and expenses hurt margins.

                                  UnitedHealth to Buy Advisory Board's Health Care Business

                                  by Zacks Equity Research

                                  The acquisition of Advisory Board's health care business will bolster UnitedHealth's (UNH) health management business.

                                    Humana (HUM) Hits 52-Week High on Solid Q2, Raised Outlook

                                    by Zacks Equity Research

                                    Humana's (HUM) shares have been favored by its strong earnings performance, guidance raise and completion of accelerated share buyback.

                                      WellCare Health Partners Mission Health to Improve Offerings

                                      by Zacks Equity Research

                                      WellCare Health Plans, Inc's (WCG) subsidiary, Wellcare of North Carolina recently entered into an agreement with Mission Health to provide better Medicaid and Medicare services in North Carolina.

                                        Centene (CNC) Poised to Grow on Buyouts, High Debt Bothers

                                        by Zacks Equity Research

                                        Centene's (CNC) accretive acquisitions backed by solid financials add to its top line. However, high debt and rising expenses hurt margins.

                                          Teladoc (TDOC) Continues to Suffer From High Operating Cost

                                          by Zacks Equity Research

                                          Teladoc's (TDOC) high expenses continue to bother. Investment expenses undertaken for business growth offer no respite on this account.

                                            Why Aetna (AET) Could Be a Top Value Stock Pick

                                            by Zacks Equity Research

                                            Aetna (AET) seems to be a good value pick, as it has impressive value metrics, and is seeing solid earnings estimate revisions as well.

                                              Here's Why Investors Should Offload LifePoint (LPNT) Stock

                                              by Zacks Equity Research

                                              LifePoint's (LPNT) lowerng of earnings guidance, soft patient volumes, soaring expenses, poor visibility for future earnings performance hurts the stock

                                                Cigna Hits 52-Week High On Strong Q2 Results, Upbeat View

                                                by Zacks Equity Research

                                                Cigna (CI) shares rally to 52-week high as strong second-quarter results, guidance increase and recent developments cheer investors.

                                                  UnitedHealth Appoints New CEO, Hemsley Takes On New Role

                                                  by Zacks Equity Research

                                                  UnitedHealth (UNH) promotes internal candidate to the role of new CEO. Current CEO assumes new responsibility.